Pharmacy Daily | FDA conviction

Other recent headlines

• 

  Guild’s ACCC submission

  Tuesday | Apr 30 2024

  THE Pharmacy Guild of Australia has formally expressed its concerns regarding the potential merger between Sigma and Chemist Warehouse (PD 07 Dec 2023) to the Australian Competition and Consumer Commission (ACCC).

  
• 

  PBS listing for Verzenio

  Tuesday | Apr 30 2024

  FROM 01 May, pharmacists will be able to dispense Verzenio (abemaciclib) through the PBS to treat Australian patients with an invasive form of early breast cancer that is at high risk of recurring after initial treatment.

  
• 

  BCNA urges swift action

  Monday | Apr 29 2024

  BREAST Cancer Network Australia (BCNA) has welcomed a PBAC recommendation to subsidise the breast cancer drug Enhertu (trastuzumab deruxtecan) for HER2-low metastatic breast cancer on the PBS.